A study team is preparing to initiate a Phase II trial for a novel colon cancer therapy. By signing the Form FDA 1572, the investigator is certifying that the investigator has:
Form FDA 1572 is the ''Statement of Investigator'' for IND studies.
21 CFR 312.53(c)(1)(vi)(b): Requires investigators to ''read and understand the Investigator's Brochure.''
By signing, the investigator also agrees to comply with regulations, maintain records, and supervise study conduct.
Other options (B--D) are not part of 1572 requirements.
Correct answer: A.
21 CFR 312.53(c)(1)(vi)(b).
Ilda
5 months agoMerri
5 months agoCaitlin
5 months agoGilma
6 months agoLuther
6 months agoHassie
6 months agoHassie
6 months agoKatlyn
7 months agoTegan
7 months agoShonda
7 months agoRima
7 months agoJulian
7 months agoAilene
8 months agoHuey
8 months ago